BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 337461)

  • 21. IgG synthesis within the brain in multiple sclerosis and subacute sclerosing panencephalitis.
    Ewan PW; Lachmann PJ
    Clin Exp Immunol; 1979 Feb; 35(2):227-35. PubMed ID: 436336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of the cerebrospinal fluid by isoelectrofocusing on agarose in multiple sclerosis].
    Clanet M; Abbal M; Munoz M; Tkaczuk J; Rascol A; Guiraud-Chaumeil B
    Rev Neurol (Paris); 1986; 142(8-9):677-82. PubMed ID: 3809854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the functional state of the blood-brain barrier by means of the analysis of total protein, albumin level and albumin index of the cerebrospinal fluid in multiple sclerosis].
    Wajgt A
    Neurol Neurochir Pol; 1980; 14(5):465-71. PubMed ID: 7453918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis: diagnostic usefulness of cerebrospinal fluid.
    Johnson KP; Nelson BJ
    Ann Neurol; 1977 Nov; 2(5):425-31. PubMed ID: 103485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis.
    Livrea P; Simone IL; Trojano M; Pisicchio L; Logroscino G; Rosato A
    Riv Neurol; 1987; 57(3):189-96. PubMed ID: 3672011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biochemical analysis of the cerebrospinal fluid in multiple sclerosis: study of various formulas].
    Rumbach L; Grucker M; Kiesmann M; Warter JM; Collard M
    Pathol Biol (Paris); 1988 Dec; 36(10):1217-20. PubMed ID: 3070462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between agarose gel electrophoresis and isoelectric focusing of CSF for demonstration of oligoclonal immunoglobulin bands in neurological disorders.
    Laurenzi MA; Link H
    Acta Neurol Scand; 1978 Sep; 58(3):148-56. PubMed ID: 31050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humans.
    Wolkowitz OM; Papadopoulos NM; Costello R; Breier A; Doran AR; Pickar D; Rubinow D
    Psychoneuroendocrinology; 1990; 15(2):155-8. PubMed ID: 2359811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis: problems in the evaluation of intrathecal IgG synthesis.
    Sheat JM; George PM; Donaldson IM
    N Z Med J; 1988 Nov; 101(858):790-2. PubMed ID: 3194076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein profile of cerebrospinal fluid in multiple sclerosis with special reference to the function of the blood brain barrier.
    Eickhoff K; Wikström J; Poser S; Bauer H
    J Neurol; 1977 Feb; 214(3):207-15. PubMed ID: 65455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis.
    Gelman BB; Rifai N; Christenson RH; Silverman LM
    Ann Clin Lab Sci; 1988; 18(1):46-52. PubMed ID: 3355096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calculation of the IgG fraction of cerebrospinal fluid locally synthesized in the central nervous system (author's transl)].
    Reiber H
    J Clin Chem Clin Biochem; 1979 Sep; 17(9):587-91. PubMed ID: 501305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate.
    Tourtellotte WW; Potvin AR; Fleming JO; Murthy KN; Levy J; Syndulko K; Potvin JH
    Neurology; 1980 Mar; 30(3):240-4. PubMed ID: 7189023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis.
    Mattson DH; Roos RP; Arnason BG
    Ann Neurol; 1981 Jan; 9(1):34-41. PubMed ID: 6163394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis.
    Blennow K; Fredman P; Wallin A; Gottfries CG; Frey H; Pirttilä T; Skoog I; Wikkelsö C; Svennerholm L
    J Neurol Sci; 1994 Jan; 121(1):90-6. PubMed ID: 8133315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of intravenous and intrathecal cytarabine to modify central nervous system IgG synthesis in multiple sclerosis.
    Tourtellotte WW; Potvin AR; Mendez M; Baumhefner RW; Potvin JH; Ma BI; Syndulko K
    Ann Neurol; 1980 Oct; 8(4):402-8. PubMed ID: 6893646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF characteristics in early-onset multiple sclerosis.
    Pohl D; Rostasy K; Reiber H; Hanefeld F
    Neurology; 2004 Nov; 63(10):1966-7. PubMed ID: 15557527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study on the concentrations of cerebrospinal fluid immunoglobulin G and albumin in children.
    Hung KL; Chang MT; Tsai ML; Chen WC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(5):325-31. PubMed ID: 1296442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody synthesis within the central nervous system: comparisons of CSF IgG indices and electrophoresis.
    Thompson EJ; Riches PG; Kohn J
    J Clin Pathol; 1983 Mar; 36(3):312-5. PubMed ID: 6826780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cerebrospinal fluid immunoglobulins. II. Variations in different pathological situations].
    Schuller E
    Nouv Presse Med; 1979 Feb; 8(6):427-32. PubMed ID: 317970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.